MilliporeSigma

Samy, director and fellow of green chemistry, helps scientists embrace sustainability in their labs with DOZN, our quantitative green chemistry evaluator. You can try DOZN too! Visit: http://ms.spr.ly/6042mVVPi

Test your knowledge with this pop quiz. Antibody Drug Conjugates, or ADCs, are revolutionizing how we treat cancer and beyond due to their targeting ability. However, producing them is tricky due to their high potency. Knowing this, can you answer the question below? Learn how the new Mobius ADC reactor can help you produce ADCs faster and safer: http://ms.spr.ly/6042mPdza

Join us on LinkedIn for a live and interactive panel discussion to explore the future of ADCs in cancer treatment. The discussion will focus on recent advancements in technology and integration with other therapies. Key topics will include innovations in antibody engineering, linker chemistry, payload selection, the role of biomarkers, and challenges in manufacturing. This event is an excellent opportunity for experts, researchers, clinicians, and industry professionals to gain insights into the latest developments and future directions of ADCs. Click Attend to RSVP.

We’re saving 3 million sheets of paper with a small change. Here’s how👇 Quality is our top priority, so nearly every product shipped comes with a Certificate of Quality. At our Jaffrey, NH site, we’ve switched from paper slips to QR codes, saving 3 million sheets of paper each year. We plan to expand this initiative to other distribution sites in the future. Read about other projects to make our packaging greener here: http://ms.spr.ly/6041mPdK7

We're teaming up with ABC’s Abbott Elementary to bring our Curiosity Cube—a solar-powered mobile science lab—to more students across the U.S.! This exciting collaboration means more students nationwide will get hands-on STEM experiences in cities like Boston, Houston, New York City, Philadelphia, and Washington, D.C. Together, we're inspiring the next generation of scientists. Don’t miss the season premiere of Abbott Elementary on Wednesday, October 9, at 9:30/8:30c on ABC and Stream on Hulu. Learn more: http://ms.spr.ly/6045mMhBR #SPARKCuriosity #AbbottElementary

What if we could tell our bodies to fight off HIV, flu, or cancer? RNA therapeutics have the potential to do just that, but they are fragile and easily broken down in the body before reaching their destination. This is where lipid nanoparticles (LNP), the protective carriers for RNA come in. Scientists like Johanna Simon — along with her colleagues from our Early Formulation Screening Service Team — help clients identify and create customized LNP. By finding the right protective carrier to deliver RNA, their therapeutics are more likely to work. Learn how Johanna and her colleagues can support bringing ideas from discovery to an impactful product for patients here: http://ms.spr.ly/6041mMChR

We are thrilled to launch the FIRST single-use reactor specifically designed to manufacture antibody-drug conjugates (ADCs). The new Mobius ADC Reactor enables biopharmaceutical companies to produce their critical therapies faster and safer. ADCs are a groundbreaking technology that targets and selectively kills tumor cells while protecting healthy ones. This new reactor is tailored precisely to meet the unique requirements for ADC manufacturing. By embracing single-use technology, the new Mobius ADC Reactor can boost manufacturing efficiency by 70% compared to traditional methods. Learn more about this innovation here: http://ms.spr.ly/6040mzQZg

🔊 We're winding down the week with the relaxing sounds of our Milli-Q Lab Water Systems.

A researcher creates a new test for an old disease. Read her story: http://ms.spr.ly/6045mDT5b Testing for Hansen’s disease—formerly known as Leprosy—used to be confined to specialized clinics. It was difficult to get tested, diagnosed, and treated, especially in remote areas, where hotspots tend to occur. Motivated by the experience of someone close to her, one researcher set out to create a more accessible testing option.

Big news! We're the FIRST in the industry to receive EXCiPACT cGMP certification for cell culture manufacturing. This certification highlights our commitment to the safety, quality, and efficacy of cell culture media used in drug components. Cell culture media is an essential raw material used in life-saving therapies and processes as varied as gene therapy, vaccine, and monoclonal antibody manufacturing. Because of its central role in biomanufacturing, a consistent supply of high-quality media is required to deliver the necessary concentration and protein quality for therapeutics. More on this news here: http://ms.spr.ly/6047mBFMf